Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Respir Med. 2013 Sep 3;107(11):10.1016/j.rmed.2013.08.018. doi: 10.1016/j.rmed.2013.08.018

Figure 1.

Figure 1

EGFR point mutations, insertions, and deletions, and KRAS point mutations detected in never smoking female (a) adenocarcinomas, (b) squamous cell carcinomas, and (c) all lung cancers

EGFR and KRAS point mutations, insertions, and deletions were mutually exclusive; One tissue had two unique EGFR point mutations; All lung cancers includes the adenosquamous cell carcinoma case in addition to the adenocarinomas and squamous cell carcinomas